2 Result: NYSE:AMPX
Buy-Rated: AMPX, RIVN, FDMT, CBAY, HTZ, PED - Unlocking Upside Potential
July 05th, 2023
Amprius Technologies, Inc. (NYSE: AMPX), a leading provider of advanced lithium-ion battery technology, was assumed by EF Hutton with a Buy rating and a price target of $14. With $AMPX closing at $6.98 on Monday, the assigned price target suggests. Read more
NewAmsterdam, Acrivon, Veeva Systems, Amprius Technologies: Latest Updates, Potential Upsides
June 04th, 2023
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) released the comprehensive findings from the ROSE2 Phase 2 clinical trial, which examined the efficacy of obicetrapib, their oral, low-dose cholesteryl ester transfer protein inhibitor, in conjunction w. Read more
Want To Find Some News?
News By Industries
Recent Post
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025
Member Login